Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Francis Medical in Maple Grove has raised about $160 million — and wants to roughly double this — as it plans for an initial ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate ...

A prostate cancer spit test has brought a national screening programme for the disease a step closer, experts have said. The ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in ...

Medically reviewed by Jamin Brahmbhatt, MD Metastatic castration-resistant prostate cancer (mCRPC) is a type of advanced ...